Importantly, TREM2 and CXCR2 directly promote the protumor functions of TAMs, and the inhibition of their expression and activity has been shown to suppress tumor growth and enhance the efficacy of tumor immune therapy [16,17,18,19]. The gene discussed is CXCR2; the disease is neoplasm.